The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase II study of bevacizumab and vorinostat for recurrent glioblastoma.
 
Ashley Ghiaseddin
No Relationships to Disclose
 
David A. Reardon
Honoraria - Merck; Roche/Genentech
Consulting or Advisory Role - Merck; Roche/Genentech
Speakers' Bureau - Merck; Roche/Genentech
 
Woody Massey
No Relationships to Disclose
 
Alexandra Mannerino
No Relationships to Disclose
 
Eric S. Lipp
No Relationships to Disclose
 
James E. Herndon
No Relationships to Disclose
 
Frances McSherry
No Relationships to Disclose
 
Annick Desjardins
Consulting or Advisory Role - Celldex; EMD Serono; Genentech; Lilly
Patents, Royalties, Other Intellectual Property - Letters Patent for ONCOLYTIC POLIOVIRUS FOR HUMAN TUMORS (Inst)
 
Dina M Randazzo
No Relationships to Disclose
 
Gordana Vlahovic
Honoraria - Genentech; Pfizer
Speakers' Bureau - Genentech; Pfizer
Travel, Accommodations, Expenses - Genentech; Pfizer
 
Henry S. Friedman
Honoraria - Arno Therapeutics; Genentech; Tactical Therapeutics
Consulting or Advisory Role - Genentech
Speakers' Bureau - Genentech
Research Funding - Genentech
 
Katherine B Peters
Research Funding - Eisai; Genentech; Merck